Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rossing

Showing results (51-60 of 131) with videos related to

Pageof 14
Sort By:
Diabetes Care|November 5, 1998
Improved visual function in IDDM patients with unchanged cumulative incidence of sight-threatening diabetic retinopathyK Rossing, P Jacobsen, P Rossing, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|May 23, 2006
Aldosterone synthase (CYP11B2)-344T/C polymorphism and renoprotective response to losartan treatment in diabetic nephropathyK J Schjoedt, M Lajer, S Andersen, et al.
Diabetologia|February 1, 1994
Glomerular size- and charge selectivity in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathyM A Gall, P Rossing, A Kofoed-Enevoldsen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 18, 2013
Urinary sulphate excretion and progression of diabetic nephropathy in Type 1 diabetesG Andrésdóttir, S J L Bakker, H P Hansen, et al.
Diabetologia|August 23, 2008
Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathyA Jorsal, L Tarnow, A Flyvbjerg, et al.
European Journal of Endocrinology|October 11, 2014
Effects of 12 weeks of treatment with fermented milk on blood pressure, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind placebo-controlled studyK D Hove, C Brøns, K Færch, et al.
Diabetes Care|June 17, 2000
Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathyL Tarnow, P Rossing, F S Nielsen, et al.
Diabetes|March 1, 1997
Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatmentP Rossing, L Tarnow, S Boelskifte, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 1, 2007
Pregnancy-associated plasma protein A in a large cohort of Type 1 diabetic patients with and without diabetic nephropathy-a prospective follow--up studyA S Astrup, L Tarnow, M Christiansen, et al.
BMJ (Clinical Research Ed.)|September 7, 1996
Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up studyH H Parving, P Jacobsen, L Tarnow, et al.
Pageof 14

Showing results (51-60 of 131) with videos related to

Sort By:
Pageof 14
Diabetes Care|November 5, 1998
Improved visual function in IDDM patients with unchanged cumulative incidence of sight-threatening diabetic retinopathyK Rossing, P Jacobsen, P Rossing, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|May 23, 2006
Aldosterone synthase (CYP11B2)-344T/C polymorphism and renoprotective response to losartan treatment in diabetic nephropathyK J Schjoedt, M Lajer, S Andersen, et al.
Diabetologia|February 1, 1994
Glomerular size- and charge selectivity in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathyM A Gall, P Rossing, A Kofoed-Enevoldsen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 18, 2013
Urinary sulphate excretion and progression of diabetic nephropathy in Type 1 diabetesG Andrésdóttir, S J L Bakker, H P Hansen, et al.
Diabetologia|August 23, 2008
Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathyA Jorsal, L Tarnow, A Flyvbjerg, et al.
European Journal of Endocrinology|October 11, 2014
Effects of 12 weeks of treatment with fermented milk on blood pressure, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind placebo-controlled studyK D Hove, C Brøns, K Færch, et al.
Diabetes Care|June 17, 2000
Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathyL Tarnow, P Rossing, F S Nielsen, et al.
Diabetes|March 1, 1997
Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatmentP Rossing, L Tarnow, S Boelskifte, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 1, 2007
Pregnancy-associated plasma protein A in a large cohort of Type 1 diabetic patients with and without diabetic nephropathy-a prospective follow--up studyA S Astrup, L Tarnow, M Christiansen, et al.
BMJ (Clinical Research Ed.)|September 7, 1996
Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up studyH H Parving, P Jacobsen, L Tarnow, et al.
Pageof 14